Skip to main content

Advertisement

Log in

Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Background

Up to 15% of patients with locally advanced renal cell carcinoma (RCC) harbors tumor thrombus (TT). In those cases, radical nephrectomy (RN) and thrombectomy represents the standard of care. We assessed the impact of TT on long-term functional and oncological outcomes in a large contemporary cohort.

Methods

Within a prospective maintained database, 1207 patients undergoing RN for non-metastatic RCC between 2000 and 2021 at a single tertiary centre were identified. Of these, 172 (14%) harbored TT. Multivariable logistic regression analyses evaluated the impact of TT on the risk of postoperative acute kidney injury (AKI). Multivariable Poisson regression analyses estimated the risk of long-term chronic kidney disease (CKD). Kaplan Meier plots estimated disease-free survival and cancer specific survival. Multivariable Cox regression models assessed the main predictors of clinical progression (CP) and cancer specific mortality (CSM).

Results

Patients with TT showed lower BMI (24 vs. 26 kg/m2) and preoperative Hb (11 vs. 14 g/mL; all—p < 0.05). Clinical tumor size was higher in patients with TT (9.6 vs. 6.5 cm; p < 0.001). After adjusting for potential confounders, the presence of TT was significantly associated with a higher risk of postoperative AKI (OR 2.03, 95% CI 1.49–3.6; p < 0.001) and long-term CKD (OR: 1.32, 95% CI 1.10–1.58; p < 0.01). Notably, patients with TT showed worse long-term oncological outcomes and TT was a predictor for CP (2.02, CI 95% 1.49–2.73, p < 0.001) and CSM (HR 1.61, CI 95% 1.04–2.49, p < 0.03).

Conclusions

The presence of TT in RCC patients represents a key risk factor for worse perioperative, as well as long-term renal function. Specifically, patients with TT harbor a significant and early estimated glomerular filtration rate (eGFR) decrease. However, despite TT patients show a greater eGFR decline after surgery, they retain acceptable renal function, which remains stable over time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

All data supporting the findings of this study are available within the paper and its material.

References

  1. Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J et al (2019) Epidemiology of renal cell carcinoma. Eur Urol 75:74–84. https://doi.org/10.1016/j.eururo.2018.08.036

    Article  PubMed  Google Scholar 

  2. Capitanio U, Montorsi F (2016) Renal cancer. Lancet 387:894–906. https://doi.org/10.1016/S0140-6736(15)00046-X

    Article  PubMed  Google Scholar 

  3. Marshall FF, Dietrick DD, Baumgartner WA, Reitz BA (1988) Surgical management of renal cell carcinoma with intracaval neoplastic extension above the hepatic veins. J Urol 139:1166–1172. https://doi.org/10.1016/s0022-5347(17)42848-5

    Article  CAS  PubMed  Google Scholar 

  4. Huang WC, Becher E (2020) Current landscape of advanced and metastatic renal cell carcinoma management. Urol Clin North Am 47:xiii–xiv. https://doi.org/10.1016/j.ucl.2020.05.001

    Article  PubMed  Google Scholar 

  5. Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H (2004) The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int 94:33–41. https://doi.org/10.1111/j.1464-410X.2004.04897.x

    Article  PubMed  Google Scholar 

  6. Musso G, Fallara G, Rosiello G, Martini A, Re C, Cei F et al (2023) Differential prognostic value of extrarenal involvement in patients with non-metastatic renal cell cancer. Clin Genitourin Cancer. https://doi.org/10.1016/j.clgc.2023.02.008

    Article  PubMed  Google Scholar 

  7. Blute ML, Boorjian SA, Leibovich BC, Lohse CM, Frank I, Karnes RJ (2007) Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy. J Urol 178:440–445; discussion 444. https://doi.org/10.1016/j.juro.2007.03.121

  8. Haddad AQ, Wood CG, Abel EJ, Krabbe L-M, Darwish OM, Thompson RH et al (2014) Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort. J Urol 192:1050–1056. https://doi.org/10.1016/j.juro.2014.03.111

    Article  PubMed  Google Scholar 

  9. Gettman MT, Boelter CW, Cheville JC, Zincke H, Bryant SC, Blute ML (2003) Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. J Urol 169:1282–1286. https://doi.org/10.1097/01.ju.0000049093.03392.cc

    Article  PubMed  Google Scholar 

  10. Rosiello G, Larcher A, Fallara G, Basile G, Cignoli D, Colandrea G et al (2020) The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery. World J Urol. https://doi.org/10.1007/s00345-020-03504-5

    Article  PubMed  PubMed Central  Google Scholar 

  11. Nini A, Muttin F, Cianflone F, Carenzi C, Luciano R, Catena M, Larcher A, Salvioni M, Cazzaniga W, Pederzoli F, Matloob R, Colombo R, Paganelli M, Salonia A, Briganti A, Doglioni C, Zangrillo A, De Cobelli F, Rigatti P, Freschi M, Cornero G, Nicoletti R, Aldrighetti L, Montorsi F, Capitanio U, Bertini R (2021) Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience. Minerva Urol Nephrol 73(6):746–753. https://doi.org/10.23736/S2724-6051.20.03844-8. Epub 2020 Nov 27. PMID: 33242949

  12. Aj V, Dd S (2015) Guidelines for reporting of statistics in European Urology. Eur Urol 67:181–187. https://doi.org/10.1016/J.EURURO.2014.06.024

    Article  Google Scholar 

  13. Chen X, Li S, Xu Z, Wang K, Fu D, Liu Q et al (2015) Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience. World J Surg Oncol 13:14. https://doi.org/10.1186/s12957-015-0448-2

    Article  PubMed  PubMed Central  Google Scholar 

  14. Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV et al (2006) chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 7:735–740. https://doi.org/10.1016/S1470-2045(06)70803-8

    Article  PubMed  PubMed Central  Google Scholar 

  15. Shirasaki Y, Tsushima T, Saika T, Nasu Y, Kumon H (2004) Kidney function after nephrectomy for renal cell carcinoma. Urology 64:43–47; discussion 48. https://doi.org/10.1016/j.urology.2004.02.039

  16. Bokka S, Manikandan R, Dorairajan LN, Srivathsa K, Sreenivasan Sreerag K, Kalra S et al (2022) Perioperative and oncological outcomes of renal cell carcinoma with venous tumour thrombus. Urologia 89:31–37. https://doi.org/10.1177/03915603211007030

    Article  PubMed  Google Scholar 

  17. Tang Q, Song Y, Li X, Meng M, Zhang Q, Wang J et al (2015) Prognostic outcomes and risk factors for patients with renal cell carcinoma and venous tumor thrombus after radical nephrectomy and thrombectomy: the prognostic significance of venous tumor thrombus level. Biomed Res Int 2015:163423. https://doi.org/10.1155/2015/163423

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Al Otaibi M, Abou Youssif T, Alkhaldi A, Sircar K, Kassouf W, Aprikian A et al (2009) Renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcome. BJU Int 104:1467–1470. https://doi.org/10.1111/j.1464-410X.2009.08575.x

    Article  PubMed  Google Scholar 

  19. Rosiello G, Larcher A, Fallara G, Giancristofaro C, Martini A, Re C et al (2022) Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma. Urol Oncol. https://doi.org/10.1016/j.urolonc.2021.12.010

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

Pietro Scilipoti: project development, data collection, manuscript writing; Giuseppe Rosiello: project development, data collection, data analyses, manuscript writing; Alessandro Larcher: project development, manuscript writing; Giuseppe Fallara: data collection, manuscript editing; Daniele Cignoli: data collection, manuscript editing; Chiara Re: data collection, manuscript editing; Giacomo Musso: data collection, manuscript editing; Francesco Cei: data collection, manuscript editing; Zhe Tian: data analyses; Pierre I. Karakiewicz: data collection, manuscript editing; Alexandre Mottrie: data collection, manuscript editing; Francesco Trevisani: data collection, manuscript editing; Daniele Raggi: data collection, manuscript editing; Andrea Necchi: data collection, manuscript editing; Roberto Bertini: project development, data collection, manuscript writing; Andrea Salonia: project development, data collection, manuscript writing; Alberto Briganti: project development, data collection, manuscript writing; Francesco Montorsi: project development, data collection, manuscript writing; Umberto Capitanio: project development, data collection, data analyses, manuscript writing.

Corresponding author

Correspondence to Giuseppe Rosiello.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Ethics approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scilipoti, P., Rosiello, G., Larcher, A. et al. Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus. World J Urol 42, 264 (2024). https://doi.org/10.1007/s00345-024-04976-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00345-024-04976-5

Keywords

Navigation